Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-08-06Compassion Focused Therapy (CFT) for the Reduction of the Internalized Stigma of Mental Disorders: a Multi-center, Prospective, Randomized, Controlled Study
-
CLINICAL_TRIALS study record update · 2025-08-05Effect of Addition of Modafinil on the Tolerability and Efficacy for Cognition of Atypical Antipsychotic Drugs in Patients With Schizophrenia or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2025-08-05D-serine Augmentation of Neuroplasticity-based Auditory Learning in Schizophrenia: R33 Phase
-
CLINICAL_TRIALS study record update · 2025-08-05Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-08-03Pharmacogenomic and Pharmacoepigenomic Studies of Antipsychotic Drugs in First-Episode Schizophrenia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-08-03Effects of the Magnetic Transcranial Stimulation (TMS) in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2025-08-03Investigation of Clinical, Cognitive and Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
-
CLINICAL_TRIALS study record update · 2025-08-01Study of the Links Between Perception of Temporal Order Judgment and Causality in Schizophrenic Spectrum Disorders
-
CLINICAL_TRIALS study record update · 2025-08-01A Phase 1, Single Dose, Parallel Cohort Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TV-44749, Olanzapine for Extended-Release Injectable Suspension for Subcutaneous Use, in Chinese Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-07-31Group Program IPS: Body-esteem and Self-esteem in a Psycho-social Rehabilitation Perspective
-
CLINICAL_TRIALS study record update · 2025-07-31Correlates of Fatigue in People With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-07-31REMEDEMPLOI: Social Cognition Training and Vocational Rehabilitation
-
CLINICAL_TRIALS study record update · 2025-07-30An Adaptive, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)
-
CLINICAL_TRIALS study record update · 2025-07-29Transcranial Direct Current Stimulation (tDCS) Studies of Behavioral and Electrophysiological (EEG) Correlates of Higher-Order Cognition
-
CLINICAL_TRIALS study record update · 2025-07-29Mindful Exercise Baduanjin Versus Brisk Walking for Cognitive Function in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-07-29Virtual Cognitive Behavioural Therapy for Psychosis: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-07-29Song-making In a Group (SING)
-
CLINICAL_TRIALS study record update · 2025-07-28A 52-week, Phase 2, Open-label Trial to Evaluate the Long-term Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-07-24Electric and Physiological Markers, Underlying Mechanisms and Modulation of Cognitive Functioning and Therapeutic Improvement in Response to tACS/CBTp (Transcranial Alternating Current Stimulation Applied at the Beginning of the Cognitive Behavioral Therapy for Psychosis Session) in Combination With the Usual Pharmacological Treatment in Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-07-24Validation of Serum Neurofilament Light Chain as a Biomarker to Differentiate Cognitive Impairment From Neurodegenerative or Psychiatric Diseases
-
CLINICAL_TRIALS study record update · 2025-07-23Applying Group Game-based Activities to Improve the Health of Patients With Chronic Mental Illness
-
CLINICAL_TRIALS study record update · 2025-07-23Safety and Efficacy of BXCL501, a Sublingual Film Delivery of Dexmedetomidine for the Treatment of Acute Agitation in Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-07-22Lost Children Society (LCS), Metacognitive Training Integrated Into an Online Therapeutic Tabletop Role-playing Game for Early-onset Schizophrenia Patients : a Pilot Study on Feasibility
-
CLINICAL_TRIALS study record update · 2025-07-17A Multi-center, Exploratory, Single-Arm, 7-week Study to Evaluate the Feasibility and Acceptability of the Medication Tracking and Educational Components of a Clinical Learning Version of CT-155 in People With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-07-14Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia: a Randomized, Double-blind, Placebo-controlled Study